| Citation: | DAI Lin-xin, XIE Jing. TCM Countermeasures for Common Clinical Problems of Refractory Mycoplasma Pneumoniae Pneumonia[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(8): 720-727. doi: 10.14148/j.issn.1672-0482.2023.0720
|
| [1] |
LI YY, GUO ZY, ZHANG GL, et al. The correlation between vitamin a status and refractory mycoplasma pneumoniae pneumonia (RMPP) incidence in children[J]. BMC pediatr, 2020, 20(1): 359. doi: 10.1186/s12887-020-02254-y
|
| [2] |
PRINCIPI N, ESPOSITO S. Macrolide-resistant mycoplasma pneumoniae: Its role in respiratory infection[J]. J Antimicrob Chemother, 2013, 68(3): 506-511. doi: 10.1093/jac/dks457
|
| [3] |
辛德莉, 王良玉. 肺炎支原体肺炎流行病学特点及耐药现状[J]. 医学与哲学(B), 2018, 39(1): 9-11. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZL201801004.htm
XIN DL, WANG LY. Epidemiological characteristics and drug resistance of mycoplasma pneumoniae pneumonia[J]. Med Philos B, 2018, 39(1): 9-11. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZL201801004.htm
|
| [4] |
ZHAO F, LI J, LIU JR, et al. Antimicrobial susceptibility and molecular characteristics of mycoplasma pneumoniae isolates across different regions of China[J]. Antimicrob Resist Infect Control, 2019, 8: 143. doi: 10.1186/s13756-019-0576-5
|
| [5] |
鲍汝英, 徐国成. 儿童难治性肺炎支原体肺炎的发病机制及治疗进展[J]. 齐齐哈尔医学院学报, 2022, 43(13): 1274-1278. https://www.cnki.com.cn/Article/CJFDTOTAL-QQHB202213017.htm
BAO RY, XU GC. Progress om mechanism and treatment of refractory mycoplasma pneumoniae pneumonia in children[J]. J Qiqihar Med Univ, 2022, 43(13): 1274-1278. https://www.cnki.com.cn/Article/CJFDTOTAL-QQHB202213017.htm
|
| [6] |
谭丹, 姜之炎. 中医药治疗儿童肺炎支原体肺炎的机制研究进展[J]. 中华中医药学刊, 2018, 36(6): 1403-1406. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201806031.htm
TAN D, JIANG ZY. Research progress on mechanism of traditional Chinese medicine in treating mycoplasma pneumonia in children[J]. Chin Arch Tradit Chin Med, 2018, 36(6): 1403-1406. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201806031.htm
|
| [7] |
TAMURA A, MATSUBARA K, TANAKA T, et al. Methylprednisolone pulse therapy for refractory mycoplasma pneumoniae pneumonia in children[J]. J Infect, 2008, 57(3): 223-228. doi: 10.1016/j.jinf.2008.06.012
|
| [8] |
刘瀚旻, 马融. 儿童肺炎支原体肺炎中西医结合诊治专家共识(2017年制定)[J]. 中国实用儿科杂志, 2017, 32(12): 881-885. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201712001.htm
LIU HM, MA R. Expert consensus on integrated traditional Chinese and western medicine in the diagnosis and treatment of mycoplasma pneumoniae in children(2017)[J]. Chin J Pract Pediatr, 2017, 32(12): 881-885. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201712001.htm
|
| [9] |
OU ZY, ZHOU R, WANG FH, et al. Retrospective analysis of mycoplasma pneumoniae infection in pediatric fatal pneumonia in Guangzhou, South China[J]. Clin Pediatr, 2008, 47(8): 791-796. doi: 10.1177/0009922808318339
|
| [10] |
闫军, 叶海燕. 108例儿童肺炎支原体肺炎的临床特点及并发症分析[J]. 重庆医学, 2008, 37(11): 1224-1226. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX200811042.htm
YAN J, YE HY. Clinical characteristics and complications of 108 children with mycoplasma pneumoniae pneumonia[J]. Chongqing Med, 2008, 37(11): 1224-1226. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX200811042.htm
|
| [11] |
张倩解, 童玲, 张金, 等. 青岛地区儿童重症社区获得性肺炎肺泡灌洗液病原及药敏分析[J]. 中国小儿急救医学, 2022, 29(4): 292-295. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX202023005.htm
ZHANG QJ, TONG L, ZHANG J, et al. Analysis of pathogens and drug sensitivity in bronchoalveolar lavage fluid of children with severe community acquired pneumonia in Qingdao area[J]. Chin Pediatr Emerg Med, 2022, 29(4): 292-295. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX202023005.htm
|
| [12] |
YANG HJ, SONG DJ, SHIM JY. Mechanism of resistance acquisition and treatment of macrolide-resistant mycoplasma pneumoniae pneumonia in children[J]. Korean J Pediatr, 2017, 60(6): 167-174. doi: 10.3345/kjp.2017.60.6.167
|
| [13] |
LI SL, XUE GH, ZHAO HQ, et al. Quantitative proteomics analysis of mycoplasma pneumoniae identifies potential macrolide resistance determinants[J]. AMB Express, 2021, 11(1): 26. doi: 10.1186/s13568-021-01187-8
|
| [14] |
吴琼, 李艳华, 廖震, 等. 儿童难治性支原体肺炎感染病原菌特点和耐药性分析及血清白细胞介素-18、33变化研究[J]. 中国基层医药, 2019, 26(21): 2607-2611.
WU Q, LI YH, LIAO Z, et al. Characteristic and drug resistance of pathogens in children with intractable mycoplasma pneumonia and changes of serum IL-18 and IL-33 levels[J]. Chin J Prim Med Pharm, 2019, 26(21): 2607-2611.
|
| [15] |
冯孝强, 高春燕. 小儿难治性肺炎支原体肺炎免疫机制及治疗研究进展[J]. 临床合理用药杂志, 2016, 9(13): 174-176. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201613114.htm
FENG XQ, GAO CY. Research progress on immune mechanism and treatment of refractory mycoplasma pneumoniae pneumonia in children[J]. Chin J Clin Ration Drug Use, 2016, 9(13): 174-176. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201613114.htm
|
| [16] |
XU QY, ZHANG LQ, HAO CL, et al. Prediction of bronchial mucus plugs formation in patients with refractory mycoplasma pneumoniae pneumonia[J]. J Trop Pediatr, 2017, 63(2): 148-154.
|
| [17] |
王亨, 赵顺英. 儿童难治性肺炎支原体肺炎的发病机制和诊治研究进展[J]. 世界临床药物, 2020, 41(5): 389-398. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH202005014.htm
WANG H, ZHAO SY. Research progress in pathogenesis, diagnosis and treatment of mycoplasma pneumoniae pneumonia in children[J]. World Clin Drug, 2020, 41(5): 389-398. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH202005014.htm
|
| [18] |
邵琴楠, 何玲. 肺炎支原体致机体高凝状态的机制研究进展[J]. 中国中西医结合儿科学, 2021, 13(5): 384-387. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYEK202105004.htm
SHAO QN, HE L. Research progress in the mechanism of mycoplasma pneumoniae causing hypercoagulability[J]. Chin Pediatr Integr Tradit West Med, 2021, 13(5): 384-387. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYEK202105004.htm
|
| [19] |
ZHANG XX, CHEN ZR, GU WJ, et al. Viral and bacterial co-infection in hospitalised children with refractory mycoplasma pneumoniae pneumonia[J]. Epidemiol Infect, 2018, 146(11): 1384-1388. doi: 10.1017/S0950268818000778
|
| [20] |
龙婷文, 代继宏. 儿童难治性肺炎支原体肺炎的诊治进展[J]. 现代医药卫生, 2020, 36(19): 3138-3141. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS202019044.htm
LONG TW, DAI JH. Progress in diagnosis and treatment of refractory mycoplasma pneumoniae pneumonia in children[J]. J Mod Med Heath, 2020, 36(19): 3138-3141. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS202019044.htm
|
| [21] |
TONG L, HUANG SM, ZHENG C, et al. Refractory mycoplasma pneumoniae pneumonia in children: Early recognition and management[J]. J Clin Med, 2022, 11(10): 2824. doi: 10.3390/jcm11102824
|
| [22] |
SUN LL, YE C, ZHOU YL, et al. Meta-analysis of the clinical efficacy and safety of high- and low-dose methylprednisolone in the treatment of children with severe mycoplasma pneumoniae pneumonia[J]. Pediatr Infect Dis J, 2020, 39(3): 177-183. doi: 10.1097/INF.0000000000002529
|
| [23] |
曾妍, 陈钟英, 何樨, 等. 不同剂量甲泼尼龙治疗难治性肺炎支原体肺炎的疗效及安全性分析[J]. 中国实用医药, 2022, 17(22): 23-26. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202222006.htm
ZENG Y, CHEN ZY, HE X, et al. Efficacy and safety analysis of different doses of methylprednisolone in the treatment of refractory mycoplasma pneumoniae pneumonia[J]. China Pract Med, 2022, 17(22): 23-26. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202222006.htm
|
| [24] |
赵春兰, 赵梅, 王运芬, 等. 儿童难治性肺炎支原体肺炎的危险因素及甲泼尼龙治疗的最佳剂量探讨[J]. 现代生物医学进展, 2022, 22(11): 2181-2185. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202211036.htm
ZHAO CL, ZHAO M, WANG YF, et al. Risk factors of refractory mycoplasma pneumoniae pneumonia in children and explore the optimal dose of methylprednisolone treatment[J]. Prog Mod Biomed, 2022, 22(11): 2181-2185. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202211036.htm
|
| [25] |
史晓云, 栾海丽, 张晗, 等. 儿童难治性肺炎支原体肺炎的支气管镜下特征及支气管肺泡灌洗液中炎症因子水平的研究[J]. 国际儿科学杂志, 2017, 44(12): 867-871. https://www.cnki.com.cn/Article/CJFDTOTAL-KMYX201607017.htm
SHI XY, LUAN HL, ZHANG H, et al. Bronchoscopic characteristics of mycoplasma pneumoniae in children and the level of inflammatory factors in bronchoalveolar lavage fluid[J]. Int J Pediatr, 2017, 44(12): 867-871. https://www.cnki.com.cn/Article/CJFDTOTAL-KMYX201607017.htm
|
| [26] |
梁世佳, 李玖军. 儿童难治性支原体肺炎诊疗进展[J]. 社区医学杂志, 2020, 18(4): 304-308. https://www.cnki.com.cn/Article/CJFDTOTAL-SQYX202004023.htm
LIANG SJ, LI JJ. Progress in diagnosis and treatment of refractory mycoplasma pneumonia in children[J]. J Community Med, 2020, 18(4): 304-308. https://www.cnki.com.cn/Article/CJFDTOTAL-SQYX202004023.htm
|
| [27] |
贺红安, 张葆青, 王晓, 等. 小儿难治性肺炎支原体肺炎中医研究概述[J]. 山东中医杂志, 2021, 40(3): 319-323. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY202103022.htm
HE HA, ZHANG BQ, WANG X, et al. Study overview of traditional Chinese medicine treatment of refractory mycoplasmal pneumoniae pneumonia in children[J]. Shandong J Tradit Chin Med, 2021, 40(3): 319-323. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY202103022.htm
|
| [28] |
马融. 中医儿科学[M]. 北京: 中国中医药出版社, 2016: 267.
MA R. Pediatrics of Traditional Chinese Medicine[M]. Beijing: China traditional Chinese medicine press, 2016: 267.
|
| [29] |
杨春, 梁文旺, 李日东. 麻杏石甘汤治疗小儿支原体肺炎的优势及机制探析[J]. 世界中医药, 2019, 14(3): 691-695. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA201903038.htm
YANG C, LIANG WW, LI RD. Advantages and mechanism of Maxing Shigan Decoction in the treatment of mycoplasma pneumonia in children[J]. World Chin Med, 2019, 14(3): 691-695. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZA201903038.htm
|
| [30] |
舒静, 陈芳, 闫慧敏. 儿童难治性肺炎支原体肺炎中医证型特点之理论探讨[J]. 中国中医急症, 2018, 27(5): 871-873. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201805032.htm
SHU J, CHEN F, YAN HM. Theoretical study on TCM syndrome types of refractory mycoplasma pneumoniae pneumonia in children[J]. J Emerg Tradit Chin Med, 2018, 27(5): 871-873. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201805032.htm
|
| [31] |
姜永红, 虞坚尔, 姜之炎. 从"肺络"探讨小儿支原体肺炎的防治[J]. 天津中医药, 2012, 29(1): 52-53. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201201018.htm
JIANG YH, YU JE, JIANG ZY. Approach the prevention and cure of children mycoplasma pneumonia from "pulmonary collaterals"[J]. Tianjin J Tradit Chin Med, 2012, 29(1): 52-53. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201201018.htm
|
| [32] |
刘璇, 马融. 马融治疗小儿重症支原体肺炎经验[J]. 湖南中医杂志, 2014, 30(7): 30-31. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201407015.htm
LIU X, MA R. Ma Rong's experience in treating severe mycoplasma pneumonia in children[J]. Hunan J Tradit Chin Med, 2014, 30(7): 30-31. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201407015.htm
|
| [33] |
TAKAHASHI I, ISHIHARA M, OISHI T, et al. Common carotid arteritis and polymyalgia with mycoplasma pneumoniae infection[J]. J Infect Chemother, 2019, 25(4): 281-284.
|
| [34] |
LI TH, YU HY, HOU WN, et al. Evaluation of variation in coagulation among children with mycoplasma pneumoniae pneumonia: A case-control study[J]. J Int Med Res, 2017, 45(6): 2110-2118.
|
| [35] |
XIAO Z, JIANG YH, GAO X, et al. Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on mycoplasma pneumoniae pneumonia[J]. J Nat Med, 2017, 71(4): 685-692.
|
| [36] |
韩耀巍, 李新民, 杜洪喆, 等. "宣肺清热, 化瘀通络"法治疗小儿肺炎支原体肺炎风热闭肺证患者266例疗效分析[J]. 天津中医药, 2019, 36(9): 869-872. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201909010.htm
HAN YW, LI XM, DU HZ, et al. Therapeutic effect analysis of 266 cases of mycoplasma pneumoniae pneumonia in children with wind and head blocking the lung syndrome by "Xuanfei Qingre, Huayu Tongluo" method[J]. Tianjin J Tradit Chin Med, 2019, 36(9): 869-872. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201909010.htm
|
| [37] |
王楠, 齐兆东, 侯宏彬, 等. 从"肺痹"理论谈难治性肺炎支原体肺炎[J]. 长春中医药大学学报, 2021, 37(3): 489-492. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX202103006.htm
WANG N, QI ZD, HOU HB, et al. Discussion on the refractory mycoplasma pneumonia by reference to the theory of "lung bi"[J]. J Chang Univ Chin Med, 2021, 37(3): 489-492. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX202103006.htm
|
| [38] |
梁旋, 谢静. 从瘀论治小儿难治性肺炎支原体肺炎[J]. 中医临床研究, 2022, 14(19): 102-104. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLY202219030.htm
LIANG X, XIE J. Treating refractory mycoplasma pneumoniae pneumonia in children from the aspect of stasis[J]. Clin J Chin Med, 2022, 14(19): 102-104. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLY202219030.htm
|
| [39] |
邬霄霞, 李焕敏, 李艳娇, 等. 近20年中医药治疗小儿肺炎支原体肺炎的知识图谱可视化分析[J]. 中医药导报, 2022, 28(12): 204-210, 219.
WU XX, LI HM, LI YJ, et al. Visual analysis on research status and hot spots of traditional Chinese medicine in the treatment of mycoplasma pneumoniae pneumonia in children in recent 20 years[J]. Guid J Tradit Chin Med Pharm, 2022, 28(12): 204-210, 219.
|
| [40] |
梁旋. 加味五虎汤治疗小儿支原体肺炎痰热闭肺证的临床观察[D]. 长沙: 湖南中医药大学, 2022.
LIANG X. Clinical observation on Jiawei Wuhu Decoction in treating children mycoplasma pneumonia with phlegm-heat blocking lung syndrome[D]. Changsha: Hunan University of Chinese Medicine, 2022.
|
| [41] |
柴琳, 张俊, 李萌, 等. 8种中草药材提取物体外抗人肺炎支原体活性研究[J]. 实用中医药杂志, 2022, 38(7): 1260-1264. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYAO202207096.htm
CHAI L, ZHANG J, LI M, et al. Study on anti-mycoplasma pneumoniae activity in vitro of eight kinds of Chinese herbal medicine extracts[J]. J Pract Tradit Chin Med, 2022, 38(7): 1260-1264. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYAO202207096.htm
|
| [42] |
宋丹, 魏文峰, 张婕, 等. 黄芩有效成分抗支原体作用及机制的研究进展[J]. 中华中医药学刊, 2023, 41(4): 226-229. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202304047.htm
SONG D, WEI WF, ZHANG J, et al. Research progress on anti mycoplasma effect and mechanism of effective components of Huangqin(Scutellaria baicalensis Georgi)[J]. Chin Arch Tradit Chin Med, 2023, 41(4): 226-229. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202304047.htm
|
| [43] |
孙艳平, 董秀华. 黄芩苷体外诱导肺炎支原体耐药的实验研究[J]. 中医药信息, 2010, 27(4): 115-116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN201004058.htm
SUN YP, DONG XH. Experimental study on baicalin inducing drug resistance of mycoplasma pneumoniae in vitro[J]. Inf Tradit Chin Med, 2010, 27(4): 115-116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN201004058.htm
|
| [44] |
张玲. 沙参麦冬汤加减治疗小儿支原体感染性肺炎临床观察[J]. 内蒙古中医药, 2017, 36(2): 44. https://www.cnki.com.cn/Article/CJFDTOTAL-NZYY201702046.htm
ZHANG L. Clinical observation on the treatment of mycoplasma pneumonia in children with Shashen Maidong Decoction[J]. Nei Mongol J Tradit Chin Med, 2017, 36(2): 44. https://www.cnki.com.cn/Article/CJFDTOTAL-NZYY201702046.htm
|
| [45] |
袁培培, 侯颖, 李潘营, 等. 基于中药功效药理学的葶苈子沉降药性研究[J]. 中药药理与临床, 2022, 38(2): 124-131. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202202024.htm
YUAN PP, HOU Y, LI PY, et al. Sedimentation effect of Tinglizi based on the pharmacology of Chinese medicine efficacy[J]. Pharmacol Clin Chin Mater Med, 2022, 38(2): 124-131. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL202202024.htm
|
| [46] |
曾令阳, 王梓懿, 何翠薇. 矮地茶化学成分与药理作用研究进展[J]. 广西科学, 2019, 26(5): 484-489. https://www.cnki.com.cn/Article/CJFDTOTAL-GXKK201905006.htm
ZENG LY, WANG ZY, HE CW. Research progress on chemical composition and pharmacological action of Ardisia Japonica[J]. Guangxi Sci, 2019, 26(5): 484-489. https://www.cnki.com.cn/Article/CJFDTOTAL-GXKK201905006.htm
|
| [47] |
WANG X, ZHONG LJ, CHEN ZM, et al. Necrotizing pneumonia caused by refractory mycoplasma pneumonia pneumonia in children[J]. World J Pediatr, 2018, 14(4): 344-349.
|
| [48] |
滕绘敏. 中医辨证治疗小儿肺炎支原体感染临床观察[J]. 光明中医, 2020, 35(5): 641-643. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202005007.htm
TENG HM. Clinical observation on treatment of mycoplasma pneumoniae infection in children with TCM syndrome differentiation[J]. Guangming J Chin Med, 2020, 35(5): 641-643. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202005007.htm
|
| [49] |
刘小敏, 庄承, 梅玉霞, 等. 豁痰通络汤治疗儿童难治性肺炎支原体肺炎的临床效果及对免疫功能的影响[J]. 广西医学, 2020, 42(20): 2639-2642. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX202020008.htm
LIU XM, ZHUANG C, MEI YX, et al. Clinical efficacy of Huotan Tongluo Decoction for treating pediatric refractory mycoplasma pneumoniae pneumonia and its impact on immune function[J]. Guangxi Med J, 2020, 42(20): 2639-2642. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX202020008.htm
|
| [50] |
李用粹. 证治汇补[M]. 太原: 山西科学技术出版社, 2011: 38.
LI YC. Syndrome, Treatment and Related Replenishment[M]. Taiyuan: shanxi science and technology publishing house, 2011: 38.
|
| [51] |
彭文, 蒲娟. 难治性支原体肺炎患儿相关炎性因子特征分析[J]. 中国妇幼保健, 2019, 34(8): 1793-1795. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201908034.htm
PENG W, PU J. Characteristics of inflammatory factors in children with refractory mycoplasma pneumonia[J]. Matern Child Heath Care China, 2019, 34(8): 1793-1795. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201908034.htm
|
| [52] |
边红恩, 陈团营, 单海军. 麻杏石甘汤联合阿奇霉素对小儿支原体肺炎患者抗炎、促炎因子及免疫功能的影响[J]. 中国实验方剂学杂志, 2017, 23(22): 177-181. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201722031.htm
BIAN HE, CHEN TY, SHAN HJ. Effect of Maxing Shigan Tang combined with azithromycin on anti-inflammatory, pro-inflammatory cytokines and immune function of mycoplasma pneumonia children[J]. Chin J Exp Tradit Med Formulae, 2017, 23(22): 177-181. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201722031.htm
|
| [53] |
范海婷, 杨一民. 麻杏石甘汤治疗小儿肺系疾病的研究进展[J]. 中国民族民间医药, 2022, 31(12): 63-66. https://www.cnki.com.cn/Article/CJFDTOTAL-MZMJ202212021.htm
FAN HT, YANG YM. Research progress of Maxing Shigan Decoction in treating children's pulmonary diseases[J]. Chin J Ethnomed Ethnopharmacy, 2022, 31(12): 63-66. https://www.cnki.com.cn/Article/CJFDTOTAL-MZMJ202212021.htm
|
| [54] |
杨月玲. 加味五虎汤在小儿支原体肺炎治疗中的应用[J]. 光明中医, 2023, 38(5): 885-888. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202305026.htm
YANG YL. The application of modified Wuhu Decoction in the treatment of mycoplasma pneumonia in children[J]. Guangming J Chin Med, 2023, 38(5): 885-888. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202305026.htm
|
| [55] |
杨昱斌, 范欣生, 周丽萍, 等. 桑白皮及其相关方剂治疗呼吸系统疾病的研究进展[J]. 中国实验方剂学杂志, 2022, 28(19): 241-249. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202219028.htm
YANG YB, FAN XS, ZHOU LP, et al. Prescriptions with Mori cortex in treatment of respiratory diseases: A review[J]. Chin J Exp Tradit Med Form, 2022, 28(19): 241-249. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202219028.htm
|
| [56] |
张惠珍. 中西医结合治疗小儿支原体肺炎临床研究[J]. 中医学报, 2016, 31(10): 1475-1478. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201610012.htm
ZHANG HZ. Clinical study on combination of Chinese and western medicine in the treatment of mycoplasma pneumonia in children[J]. Acta Chin Med, 2016, 31(10): 1475-1478. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201610012.htm
|
| [57] |
王峥, 王亚君, 满晓静, 等. 红景天治疗心血管疾病研究进展[J]. 创伤与急危重病医学, 2019, 7(4): 258-259, 262. https://www.cnki.com.cn/Article/CJFDTOTAL-CSJB201904022.htm
WANG Z, WANG YJ, MAN XJ, et al. Research progress of rhodiola sachalinensis in treating cardiovascular diseases[J]. Trauma Crit Care Med, 2019, 7(4): 258-259, 262. https://www.cnki.com.cn/Article/CJFDTOTAL-CSJB201904022.htm
|
| [58] |
潘炜, 叶姗, 王忠敏, 等. 豁痰通络汤治疗难治性肺炎支原体肺炎患儿的疗效[J]. 辽宁中医杂志, 2023, 50(6): 123-126.
PAN W, YE S, WANG ZM, et al. Effect of Huotan Tongluo Decoction on refractory mycoplasma pneumoniae pneumonia in children[J]. Liaoning J Tradit Chin Med, 2023, 50(6): 123-126.
|
| [59] |
王文彦, 张静雯, 赵瑞瑞, 等. 清肺止痉活血法联合阿奇霉素治疗小儿支原体肺炎痰热闭肺证的疗效及对血小板、D二聚体的影响[J]. 血栓与止血学, 2021, 27(2): 242-243, 246. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202102022.htm
WANG WY, ZHANG JW, ZHAO RR, et al. Effect of Qingfei Zhijing Huoxue methods combined with azithromycin in the treatment of infantile mycoplasma pneumonia with phlegm heat obstructing lung syndrome and its influence on platelet and d-dimer[J]. Chin J Thromb Hemostasis, 2021, 27(2): 242-243, 246. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202102022.htm
|
Copyright © Journal of Nanjing University of traditional Chinese Medicine
Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023
Tel：025-85811935Email：xb@njucm.edu.cn
Supported by:
Beijing Renhe Information Technology Co., Ltd.
DownLoad: